Cover Image

Distribution of insulin in primate brain following nose‐to‐brain transport

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Kylie Smith, Jinda Fan, Gwendolyn A. Marriner, John Gerdes, Robert Kessler, Kurt R. Zinn
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Alzheimer's & Dementia: Translational Research & Clinical Interventions
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Researcher photographs in recruitment materials to increase willingness to participate in brain health research
by: Christy J. W. Ledford, et al.
Published: (2026)

Association between 24‐h time‐use composition and brain age: The IGNITE study
by: Audrey M. Collins, et al.
Published: (2025)

Exploring small‐world brain connectivity in aging and its relationship with cognitive reserve
by: Chiara Pappalettera, et al.
Published: (2026)

Association of region‐specific hippocampal reduction of neurogranin with inflammasome proteins in post mortem brains of Alzheimer's disease
by: Regina T. Vontell, et al.
Published: (2024)

Building digital solutions to support brain health prescribing in primary care: Where to begin?
by: Joyce Siette, et al.
Published: (2024)

Incorporating individually defined brain health priorities in clinical trial outcomes: the electronic Person‐Specific Outcome Measure approach in the United States
by: Stina Saunders, et al.
Published: (2025)

Mapping brain change longitudinally: physical activity intervention reshapes structural alterations and functional connectivity in Alzheimer's disease
by: Ravi Dadsena, et al.
Published: (2026)

Mapping sex differences in brain and cognition in relation to APOE ε4 and amyloid burden: A longitudinal normative modelling study
by: Sivaniya Subramaniapillai, et al.
Published: (2026)

A service‐oriented approach to clinical trial recruitment for dementia and brain health: Methods and case examples of MyAlliance for Brain Health
by: Eric D. Vidoni, et al.
Published: (2024)

First‐in‐human positron emission tomography study of intranasal insulin in aging and MCI
by: Kiran K. Solingapuram Sai, et al.
Published: (2025)

Lifestyle medicine and brain health: Insights from the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) and the promise of personalization
by: Alfonso Alfini, et al.
Published: (2025)

Identification of cerebrospinal fluid pharmacodynamic biomarkers and molecular correlates of brain activity in a Phase 2 clinical trial of the Alzheimer's disease drug candidate CT1812
by: Valentina Di Caro, et al.
Published: (2025)

A sex‐specific “hormone–bone–brain” axis in Alzheimer's disease: Integrating Global Burden of Disease data and Mendelian randomization analysis to reveal the causal role of osteocalcin
by: Zhiyang Zheng, et al.
Published: (2026)

Time saved in activities of daily living and whole‐brain volume: Post hoc analysis of a randomized feasibility trial of gamma oscillation treatment in participants with mild or moderate Alzheimer's disease
by: Ralph Kern, et al.
Published: (2025)

Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatment
by: Pratik Bhagunde, et al.
Published: (2026)

Clinically meaningful benefit and real‐world evidence in Alzheimer's disease research and care
by: Robert Perneczky, et al.
Published: (2025)

Adaptive measurement of cognitive function based on multidimensional item response theory
by: Robert D. Gibbons, et al.
Published: (2024)

Development and classification accuracy of an automated cognitive screening tool combining working memory and connected speech tasks for early detection of cognitive impairment in primary care
by: Robin C. Hilsabeck, et al.
Published: (2025)

Digital biomarkers: Redefining clinical outcomes and the concept of meaningful change
by: Maria Florencia Iulita, et al.
Published: (2025)

Health and Aging Brain Study–Health Disparities (HABS‐HD) methods and partner characteristics
by: Melissa E. Petersen, et al.
Published: (2025)

Machine learning–enhanced screening funnel for clinical trials in Alzheimer's disease
by: Scott Gladstein, et al.
Published: (2025)

The utility of a composite endpoint for tracking disease progression in Lewy body dementia
by: Elie Matar, et al.
Published: (2026)

The association of dementia risk symptoms and functional activity in adults with Down syndrome
by: Selena E. Washington, et al.
Published: (2024)

A common outcome set for trials in dementia with Lewy bodies (DLB COS)
by: Joseph P. M. Kane, et al.
Published: (2025)

Participant completion of longitudinal assessments in an online cognitive aging registry: The role of medical conditions
by: Miriam T. Ashford, et al.
Published: (2024)

Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease
by: Ronald C. Petersen, et al.
Published: (2025)

Effects of care partner type on outcomes from a multicomponent behavioral intervention for mild cognitive impairment
by: Zhigang Xie, et al.
Published: (2026)

Personal value of Alzheimer's disease biomarker testing and result disclosure from the patient and care partner perspective
by: Khushbu J. Patel, et al.
Published: (2024)

Mitochondrial blood‐based biomarker is related to cardiorespiratory fitness and aging in a sex‐dependent manner
by: Riley E. Kemna, et al.
Published: (2025)

APOLLOE4 Phase 3 study of oral ALZ‐801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics
by: Susan Abushakra, et al.
Published: (2024)

Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domains
by: Gregory A. Cary, et al.
Published: (2024)

Lower CD8+ T‐cell senescence partially mediates the neuroprotection of higher aerobic fitness
by: Bernadette A. Fausto, et al.
Published: (2026)

Donanemab immunogenicity in participants with early symptomatic Alzheimer's disease
by: Garrett R. Mullins, et al.
Published: (2025)

The I‐Learn Cognition and Behavior program for non‐pharmacological treatment of agitation in nursing home residents with neurocognitive disorders: A cluster randomized trial
by: Céline Lourdel, et al.
Published: (2026)

Decentralizing dementia research to the US–Mexico border: the Rio Grande Valley AD‐RCMAR as a model for translational equity
by: Gladys E. Maestre, et al.
Published: (2026)

ACE trial design: Equol targeting estrogen receptor‐β in vascular and cognitive aging
by: Akira Sekikawa, et al.
Published: (2025)

Cost‐effectiveness of a multicomponent intervention against cognitive decline
by: Christian Brettschneider, et al.
Published: (2025)

Community‐engaged efforts to increase retention of Black American online registry participants
by: Miriam T. Ashford, et al.
Published: (2025)

Designing and implementing the IDEAL Study: A randomized clinical trial of APOE genotype disclosure for late‐onset Alzheimer's disease in an urban Latino population
by: John B. Wetmore, et al.
Published: (2024)

Infusion‐related reactions in donanemab‐treated participants with early symptomatic Alzheimer's disease
by: Paul Ardayfio, et al.
Published: (2026)